Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial
Abstract Background As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessat...
Main Authors: | John A. A. Nichols, Paul Grob, Wendy Kite, Peter Williams, Simon de Lusignan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-017-2831-2 |
Similar Items
-
Helping people stop smoking in workplaces: an alternative path
by: Joseph Osman
Published: (2016-03-01) -
Evaluating smartphone-based stop smoking interventions – opportunities and challenges.
by: Aleksandra Herbec
Published: (2017-05-01) -
English Stop-Smoking Services: One-Year Outcomes
by: Linda Bauld, et al.
Published: (2016-11-01) -
Smoking cessation Through Optimisation of clinical care in Pregnancy: the STOP randomised controlled trial
by: Brendan P. McDonnell, et al.
Published: (2019-09-01) -
Smoking-cessation support for non-Japanese
patients using the STOP SMOKING application
by: Naomi Miyamatsu, et al.
Published: (2019-10-01)